Form 8-K - Current report:
SEC Accession No. 0001104659-23-098814
Filing Date
2023-09-07
Accepted
2023-09-07 09:17:02
Documents
12
Period of Report
2023-09-06
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2325666d1_8k.htm   iXBRL 8-K 30265
  Complete submission text file 0001104659-23-098814.txt   204927

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA repl-20230906.xsd EX-101.SCH 3018
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE repl-20230906_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE repl-20230906_pre.xml EX-101.PRE 22361
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2325666d1_8k_htm.xml XML 3406
Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

EIN.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38596 | Film No.: 231241110
SIC: 2836 Biological Products, (No Diagnostic Substances)